Page 3 - Sanofi Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanofi oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanofi Oncology Today - Breaking & Trending Today

Step Pharma Appoints Experienced Cancer Drug Developer Adrian Senderowicz to Board of Directors

Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, announced today the appointment of Dr. Adrian Senderowicz to its Board of Directors. Dr. Senderowicz is a board-certified ....

France General , Andrew Parker , Kostenloser Wertpapierhandel , Sylvain Latour , Adrian Senderowicz , Mike Sinclair , School Of Medicine , Inserm Transfert Initiative , National Cancer Institute , Icahn School Of Medicine At Mount Sinai , Tokai Pharmaceuticals , Constellation Pharmaceuticals , Ignyta Inc , Step Pharma , Senior Vice President , Chief Medical Officer , Cerulean Pharma , Sanofi Oncology , Internal Medicine , Icahn School , Mount Sinai , Clinical Oncology Fellowship , Universidad De Buenos Aires , Kurma Partners , Imagine Institute , Sygnature Discovery ,

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors

Share this article
Share this article
HAMILTON, ON and BOSTON, April 1, 2021 /PRNewswire/ Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines today announced the appointment of Donald A. Bergstrom, M.D., Ph.D., as a member of the Company s Board of Directors. Dr. Bergstrom, who currently serves as executive vice president, head of research and development at Relay Therapeutics, Inc., a clinical stage precision medicines company, brings to the board more than 15 years of experience in the biopharmaceutical industry.
Don s depth of precision oncology and industry experience will be invaluable to us as we continue to progress our Targeted Alpha Therapies (TAT) platform and grow our pipeline of clinical candidates, said Fusion Chief Executive Officer John Valliant, Ph.D. Additionally, his leadership and understanding of the oncology landscape will provide ....

United States , John Valliant , Donalda Bergstrom , Johns Hopkins University , Fusion Pharmaceuticals Inc , University Of Washington , Relay Therapeutics Inc , Company Board Of Directors , Merck Research Laboratories , Fusion Pharmaceuticals , Relay Therapeutics , Targeted Alpha Therapies , Fusion Chief Executive Officer John Valliant , Mersana Therapeutics , Sanofi Oncology , Merck Research , Johns Hopkins , Fusion Board , Health Care Amp Hospitals , Medical Pharmaceuticals , Personnel Announcements , ஒன்றுபட்டது மாநிலங்களில் , ஜான் வாலியண்ட் , டொனால்டா பெர்க்ஸ்ட்ரோம் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , இணைவு மருந்துகள் இன்க் ,

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , John Valliant , Donalda Bergstrom , Johns Hopkins University , Fusion Pharmaceuticals Inc , University Of Washington , Relay Therapeutics Inc , Company Board Of Directors , Merck Research Laboratories , Fusion Pharmaceuticals , Relay Therapeutics , Targeted Alpha Therapies , Fusion Chief Executive Officer John Valliant , Mersana Therapeutics , Sanofi Oncology , Merck Research , Johns Hopkins , Fusion Board , ஒன்றுபட்டது மாநிலங்களில் , ஜான் வாலியண்ட் , டொனால்டா பெர்க்ஸ்ட்ரோம் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , இணைவு மருந்துகள் இன்க் , பல்கலைக்கழகம் ஆஃப் வாஷிங்டன் , ரிலே சிகிச்சை இன்க் , நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் ,